ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement for transfer of equity shares to Investor Education and Protection Fund ("IEPF") Authority.23-01-2023
23-01-2023
ANUH PHARMA LTD. - 506260 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants), Regulations, 2018 for the quarter ended 31st December, 2022.12-01-2023
ANUH PHARMA LTD. - 506260 - Appointment of Company Secretary and Compliance Officer
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.07-01-2023
ANUH PHARMA LTD. - 506260 - Board Meeting Outcome for Outcome Of Board Meeting Dated 6Th January, 2023.
Outcome of Board Meeting dated 6th January, 2023.06-01-2023
ANUH PHARMA LTD. - 506260 - Disclosure Of Related Party Transactions Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Circular bearing reference no. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021, please find enclosed herewith the disclosure of Related Party Transactions for the half year ended 30th September, 2022. Submitted for your information and records.15-11-2022
ANUH PHARMA LTD. - 506260 - Sub: Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015. Noting Of Resignation Of Mr. Bharat Gangani, From The Post Of Company Secretary And Compliance Officer Of The Company.
Dear Sir/Madam, Pursuant to the provisions of Regulation 30 read with Schedule III Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to inform you that the Board of Directors of the Company (the "Board") at its Meeting held on Monday, 7th November, 2022, has noted the resignation of Mr. Bharat Gangani, from the post of Company Secretary and Compliance Officer of the Company. Company has already made an intimation regarding the resignation of Mr. Bharat Gangani as a Company Secretary and Compliance Officer to the Stock Exchange on 20th October, 2022. The Meeting of the Board of Directors commenced at 12:30 PM and concluded at 3:15 PM.08-11-2022
ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Ref: Scrip Code No. 506260 Sub: Newspaper Publication of Unaudited Financial Results for the quarter ended 30.09.2022 Please find enclosed herewith the copy of newspaper advertisement with respect to the Unaudited Financial Results for the quarter ended September 30, 2022, published in the Financial Express and Mumbai Lakshadeep on Tuesday, November 08, 2022 in compliance with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kindly acknowledge the receipt and take the same on record.08-11-2022
ANUH PHARMA LTD. - 506260 - Submission Of Unaudited Financial Results For The Quarter Ended September 30, 2022 Along With Limited Review Report
Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we are enclosing herewith the following: 1. Unaudited Financial Results for the quarter ended September 30, 2022; and 2. Limited Review Report for the quarter ended September 30, 202207-11-2022
ANUH PHARMA LTD. - 506260 - Board Meeting Outcome for Outcome Of Board Meeting Dated 7Th November, 2022
Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to inform you that the Board of Directors of the Company (the "Board") at its Meeting held today i.e. Monday, 7th November, 2022, inter-alia considered and approved the following agenda Items: 1. The Un-audited Financial Results along with Limited Review Report thereon for the quarter ended 30th September, 2022. The Meeting of the Board of Directors commenced at 12:30 PM and concluded at 3:15 PM07-11-2022